Transjugular intrahepatic portosystemic stent-shunt insufficiency and the role of diabetes mellitus

European Journal of Gastroenterology and Hepatology

Volumn 13, Issue 3, 2001, Pages 257-261

  Shah, Syed H A ^a   Lui, Hock F ^a   Jalan, Rajiv ^a   Helmy, Ahmed ^a   Redhead, Doris N ^a   Penny, Kay ^a   Hayes, Peter C ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Diabetes mellitus; Shunt insufficiency; Transjugular intrahepatic portosystemic stent shunt

Indexed keywords

ADULT; ARTICLE; DIABETES MELLITUS; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GRAFT PATENCY; HUMAN; MAJOR CLINICAL STUDY; MALE; PORTAL PHLEBOGRAPHY; PORTOSYSTEMIC ANASTOMOSIS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL;

DIABETES COMPLICATIONS; FEMALE; GASTROINTESTINAL DISEASES; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC; TREATMENT FAILURE;

EID: 0035092614     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/00042737-200103000-00007     Document Type: Article

References (23)

1. Jalan R, Redhead DN, Hayes PC. A review of transjugular portosystemic stent-shunt (TIPSS) for variceal haemorrhage. Br J Surg 1995; 82: 1158-1164.
2. Latimer J, Bawa SM, Rees CJ, Hudson H, Rose JDG. Patency and re-intervention rates during routine TIPSS surveillance. Cardiovasc Interventional Radiol 1998; 21: 234-239.
3. Stanley AJ, Jalan R, Forrest EH, Redhead DN, Hayes PC. Long-term follow-up of transjugular intrahepatic portosystemic stent shunt for the treatment of portal hypertension: results in 130 patients. Gut 1996; 39: 479-485.
4. Rossle M, Haag K, Ochs A, Sellinger M, Noldge G, Perarnau JM. et al. The transjugular intrahepatic portosystemic stent-shunt procedure for variceal bleeding. N Engl J Med 1994; 330: 165-171.
5. LaBerge JM, Ring EJ, Gordon RL, Lake JR, Doherty MM, Somberg KA. et al. Creation of transjugular intrahepatic portosysternic shunts with Wallstent endoprosthesis: results in 100 patients. Radiology 1993; 187: 413-420.
6. Jalan R, Redhead DN, Simpson KJ, Elton RA, Hayes PC. Transjugular intrahepatic portosystemic stent-shunts (TIPSS): long-term follow up. Q J Med 1994; 87: 565-573.
7. Martin M, Zajko AB, Orons PPD, Dodd G, Wright H, Colangelo J, Tartar R. Transjugular intrahepatic portosystemic shunt in the management of variceal bleeding: indications and clinical results. Surgery 1993; 114: 719-727.
8. Peramau JM, Raabe JJ, Schwing D, Rucin B, Monchovet S, Rossle M, Arbogast J. Anastomose porto-cava intrahepatique par voie transjugulaire. Gastroenterol Clin Biol 1993; 17: 422-430.
9. Lind CD, Malisch TW, Chong WK, Richards WO, Pinson CW, Meranze M. Incidence of shunt occlusion or stenosis following transjugular intrahepatic portosystemic shunt placement. Gastroenterology 1994; 106: 1277-1283.
10. Jalan R, Harrison DJ, Redhead DN, Hayes PC. Transjugular intrahepatic portosystemic stent-shunt and the role of biliary venous fistula. J Hepatol 1996; 24: 169-175.
11. Dabos K, Stanley AJ, Jalan R, Redhead DN, Hayes PC. Shunt insufficiency after TIPSS; balloon angioplasty or insertion of parallel shunt [Abstract]. Gut 1996; 39 (suppl): Al1.
12. Henri D, Joe EK, Herve R, Karl B, Jean-Marie P, Marie-Therese P. et al. Histopathologic analysis of transjugular intrahepatic portosystemic shunts. Hepatology 1997; 25: 1064-1069.
13. Jalan R, Elton RA, Redhead DN, Finlayson NDC, Hayes PC. Analysis of prognostic variables in the prediction of mortality, shunt failure, variceal rebleeding and encephalopathy following the transjugular intrahepatic portosystemic stent-shunt for variceal haemorrhage. J Hepatol 1995; 23: 123-128.
14. Shearman DJC, Finlayson NDC (editors). Cirrhosis. In:Diseases of the Gastrointestinal Tract and the Liver. Edinburgh: Churchill Livingstone; 1989.
15. Aronson D, Bloorrigarden Z, Rayfield EJ. Potential mechanisms promoting restenosis in diabetic patients. J Am Coll Cardiol 1996; 27: 528-535.
16. Jalan R, Stanley AJ, Redhead DN, Hayes PC. Shunt insufficiency after transjugular portosystemic stent-shunts: the whens, whys, hows and what should we do about it? Clin Radiol 1997; 52: 329-331.
17. Vandormael MG, Deligonul U, Kem MJ, Harper M, Presant S, Gibson P. et al. Multilesion coronary angioplasty: clinical and angiographic outcome. J Am Coll Cardiol 1987; 10: 246-252.
18. Rensing BJ, Hermans RM, Vos J, Tijssen JG, Rutch W, Danchin N. et al. Luminal narrowing after percutaneous transluminal coronary angioplasty. Circulation 1993; 88: 975-985.
19. Galan KM, Hollman JL. Recurrence of stenosis after coronary angioplasty. Heart Lung 1986; 15: 585-587.
20. Weintraub WS, Kosinki AS, Brown CL, King SB. Can restenosis after coronary angioplasty be predicted from clinical variables? J Am Coll Cardiol 1993; 21: 6-14.
21. Taqkahashi K, Ghatei MA, Lam HC, O’Halloran DJ, Bloom SR. Elevated plasma endothelin in patients with diabetes mellitus. Diabetologia 1990; 33: 306-310.
22. Yamamoto T, Nakamura T, Noble NA, Rouslathi E, Border WA. Expression of transforming growth factor P is elevated in human and experimental diabetic nephropathy. Proc Natl Acad Sci USA 1993; 90: 1814-1818.
23. Meyer-Schwickerath R, Pfeiffer A, Blum WF, Freyberger H, Klein M, Losche C. et al. Vitreous levels of the insulin-like growth factors I and II, and the insulin-like growth factor binding proteins 2 and 3 increase in neovascular eye disease: studies in nondiabetic and diabetic subjects. J Clin Invest 1993; 92: 2620-2625.